| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |